In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more than eight months, more than tripled progression-free survival and reduced the risk of death by 58% compared to durvalumab alone, according to results of the phase 3 open-label, multicenter,…
The Niger State Government has inaugurated an emergency response committee and intensified preparations against Ebola following the confirmation of an imported case in the Federal Capital Territory…
Researchers studying mice and human data identified a six gene signature, and developed a scorings system, that could help forecast acute myeloid leukemia patient survival, and potentially point to…
A woman infected with the Ebola virus and her husband, a Swiss diplomat, were flown from Nigeria to hospitals in Switzerland on Monday, Swiss authorities said.
The biggest challenge facing the biopharma industry isn’t scientific innovation. It’s manufacturing execution. Closing this gap is one of the greatest opportunities biopharma has today to enhance…
The condition Joey Loperfido had addressed will delay his availability for spring training - assuming it actually begins on time given the expiring collective bargaining agreement.
